Molecular Pathways of Genistein Activity in Breast Cancer Cells
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This review explores genistein, a dietary polyphenol, for its potential to combat breast cancer. It highlights how genistein influences cancer cell signaling pathways and apoptosis for therapeutic development.
Area Of Science
- Oncology
- Molecular Biology
- Chemical Biology
Background
- Breast cancer is the most common female malignancy, often involving oncogenic transcription factors, inflammatory cytokines, and antiapoptotic proteins.
- Cancer progression, metastasis, and survival are linked to upregulated antiapoptotic proteins and dysregulated cell cycle pathways.
- Dietary phytoconstituents, particularly polyphenols, show promise in cancer prevention by modulating cellular defense mechanisms and signaling pathways.
Purpose Of The Study
- To review innovations in understanding genistein's effects on breast cancer cells.
- To present integrated chemical biology approaches for elucidating genistein's mechanisms of action.
- To explore therapeutic advances for breast cancer treatment based on polyphenol activity.
Main Methods
- Literature review focusing on genistein and breast cancer.
- Analysis of signaling pathways influenced by polyphenols, including genistein.
- Integration of chemical biology methods to study molecular mechanisms.
Main Results
- Genistein, a notable polyphenol, is under investigation for its impact on breast cancer cell behavior.
- Polyphenols interact with key cancer signaling pathways, offering potential therapeutic targets.
- Understanding the mechanisms of action of genistein is crucial for developing novel breast cancer treatments.
Conclusions
- Genistein exhibits potential as an anticancer agent against breast cancer.
- Chemical biology provides tools to unravel the complex interactions of genistein in cancer cells.
- Further research into genistein and other polyphenols can lead to significant therapeutic breakthroughs in oncology.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...